Delivery Order SPE2DB22D1017-SPE2DB25FG8BY
- Not listed
- On July 25, 2025, the Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens. This non-competitive, firm fixed-price delivery order is scheduled for completion by July 28, 2025, with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's military...
- On August 8, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,690.34 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens valued at $9,721.62. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. This delivery order is a child contract issued under...
- On August 5, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $25,774.94 to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 mL pen injectors. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 6, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this award...
- The Defense Logistics Agency awarded a $5,476.25 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to compete in open federal procurement processes for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 ml pens valued at $1,553.39. This is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $5,338.06 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,658.36 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed-price, competitively awarded contract will be fulfilled from the vendor's Conshohocken, Pennsylvania location, with an ultimate completion date of July 22, 2025. The award carries no set-aside designation, indicating it was openly competed among qualified pharmaceutical distributors. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $36,746.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectables. The contract, which represents a child order under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections with a ceiling value of $5,064.15. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is set to conclude by August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8BYDelivery Order
On July 24, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $7,569.60 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive award executed under an existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply agreement extending through December 2026. As the prime contractor on this global pharmaceutical support vehicle, AmerisourceBergen supplies a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal medical systems. The Zepbound delivery exemplifies the company's role as a critical vendor for federal pharmaceutical procurement, fulfilling ongoing medical supply requirements for the Defense Health Agency and related government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 7/24/25 |